![\"FastCo\"](\"http:\/\/www.pixelube.com\/work\/c4c\/wp-content\/uploads\/2011\/03\/FastCo1-e1301600757116.jpg\")
Fast Company has listed Fate Therapeutics in sixth place amongst their 2011 list of America\u2019s most innovative biotech companies citing Fate\u2019s innovative method for testing drugs on human cells.<\/p>\nFast Company has listed Fate Therapeutics in sixth place amongst their 2011 list of America\u2019s most innovative biotech companies citing Fate\u2019s innovative method for testing drugs on human cells.<\/p>\n
Fast Company\u2019s recognition is just the most recent example of attention that Fate Therapeutics has garnered. Just last year MIT\u2019s Technology Review cited Fate as one of the 50 most innovative companies in the world\u2014alongside Apple, GlaxoSmithKline, and Tesla Motors\u2014for its promising approach to stem cell therapy. Fate Therapeutics was conceived at UW.<\/p>\n
<\/p>\n
Visit Fast Company\u2019s 2011 list<\/a> of The Top 10 Most Innovative Companies in Biotech<\/p>\n Read the Center for Commercialization success story<\/a> on Fate Therapeutics<\/p>\n <\/p>\n About Fate Therapeutics, Inc.<\/strong><\/p>\n Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop stem cell modulators (SCMs), small molecule or biologic compounds that guide cell fate for therapeutic purposes. The Company\u2019s award-winning, proprietary iPSC technology incorporates the most advanced viral, small molecule and protein reprogramming methods and offers a highly efficient platform to recapitulate human physiology for commercial scale drug discovery and therapeutic use. The Company\u2019s approach has broad therapeutic potential in areas such as regenerative medicine, hematological diseases, metastatic cancer, traumatic injury and degenerative diseases. Fate Therapeutics is currently conducting a Phase 1b clinical trial of FT1050, a small molecule SCM designed to enhance hematopoietic stem cell support during the normal course of a stem cell transplant in patients with hematologic malignancies, such as leukemia and lymphoma. Fate Therapeutics is headquartered in San Diego, CA, with a subsidiary in Ottawa, Canada. For more information, please visit www.fatetherapeutics.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Fast Company has listed Fate Therapeutics in sixth place amongst their 2011 list of America\u2019s most innovative biotech companies citing Fate\u2019s innovative method for testing drugs on human cells. Fast […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-1119","post","type-post","status-publish","format-standard","hentry","category-general-news"],"_links":{"self":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/posts\/1119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/comments?post=1119"}],"version-history":[{"count":0,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/posts\/1119\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/media?parent=1119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/categories?post=1119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/tags?post=1119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n